AIM ImmunoTech furnishes supplemental data deck on pancreatic cancer Early Access Program

AIM ImmunoTech Inc.

Deck titled 'Pancreatic Cancer Early Access Program Supplemental Data Q1 2024' furnished as Exhibit 99.1.
Data posted on the 'Investors' section of the company's website.
No specific clinical results or financial figures disclosed in the 8-K filing.

item 7.01 item 9.01

AIM ImmunoTech Inc. filing history →

Source: SEC EDGAR

accession 0001493152-24-003779

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.